Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Global online interest in finasteride sexual side effects


Prior literature has suggested that finasteride may negatively impact men’s sexual health. In 2011, the Food and Drug Administration (FDA) provided a warning on finasteride drug labels to incorporate sexual side effects such as reduced libido and erectile dysfunction. We aimed to evaluate global online interest in finasteride sexual side effects, their penetrance and variation, and how they compared overtime. We also aimed to evaluate the influence of the FDA label warnings on web-based searches for finasteride side effects. We utilized Google search engine from January 2004 to December 2020 to include separate trends from web searches of “Propecia,” “Propecia side effects,” “finasteride”, “finasteride side effects”, and “post-finasteride syndrome” compared amongst the United States, United Kingdom, and Australia. We performed join-point regression analysis. We compared the annual relative search volume (ARSV) and annual percentage change (APC) to evaluate for loss or gain of interest in the respective key terms. We determined that the average ARSV for “finasteride” was 14.8% in 2004 and increased significantly to 57.3% in 2020 (APC: +9.25%, 95% CI 8 to 10.5, p < 0.001). Likewise, there was significant increased interest in “finasteride side effects” (APC: +20.7, p < 0.001) and “post-finasteride syndrome” (APC: +29.2; p < 0.001) in the United States overtime. Finally, when we compared trends before and after the FDA warnings, the average ASRV of “finasteride”, “finasteride side effects”, and “post-finasteride syndrome” all increased significantly (p = 0.001, p = 0.014, p < 0.001), respectively. Thus, it is evident that there is a global web-based interest in finasteride and its sexual health side effects, particularly after the FDA warning in 2011. There is boosted public awareness, and thus providers should have more detailed and careful conversations with patients prior to starting a 5α-reductase inhibitor such as finasteride.

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1: Join-point regression annual percent change (APC) curves of “finasteride” and “finasteride side effects” in the United States.
Fig. 2: Impact of FDA communications on finasteride side effects and post-finasteride syndrome treatment trends.

Data availability

The data that support the findings of this study are available in Google Trend. These data were derived from the following resources available in the public domain:


  1. Prescribing Information: PROSCAR (finasteride). 2013.

  2. Kane SP Finasteride—Drug Usage Statistics, ClinCalc DrugStats Database. 2021.

  3. Zito PM, Bistas KG, Syed K. Finasteride. Treasure Island (FL): StatPearls; 2022.

  4. Leyden J, Dunlap F, Miller B, Winters P, Lebwohl M, Hecker D, et al. Finasteride in the treatment of men with frontal male pattern hair loss. J Am Acad Dermatol. 1999;40:930–7.

    CAS  Article  Google Scholar 

  5. Drugs@FDA. FDA-Approved Drugs. 2021.

  6. Lim KB. Epidemiology of clinical benign prostatic hyperplasia. Asian J Urol. 2017;4:148–51.

    Article  Google Scholar 

  7. Busetto GM, Giovannone R, Antonini G, Rossi A, Del Giudice F, Tricarico S, et al. Short-term pretreatment with a dual 5alpha-reductase inhibitor before bipolar transurethral resection of the prostate (B-TURP): evaluation of prostate vascularity and decreased surgical blood loss in large prostates. BJU Int. 2015;116:117–23.

    CAS  Article  Google Scholar 

  8. Gupta AK, Quinlan EM, Williams KL. The shifting preferences of patients and physicians in nonsurgical hair loss treatment. J Cosmet Dermatol. 2021;20:929–36.

    Article  Google Scholar 

  9. Traish AM. Health Risks Associated with Long-Term Finasteride and Dutasteride Use: It’s Time to Sound the Alarm. World J Mens Health. 2020;38:323–37.

    Article  Google Scholar 

  10. Kuehn BM. Prostate, baldness drugs linked to sexual dysfunction. JAMA. 2012;307:1903.

    CAS  Article  Google Scholar 

  11. Mella JM, Perret MC, Manzotti M, Catalano HN, Guyatt G. Efficacy and safety of finasteride therapy for androgenetic alopecia: a systematic review. Arch Dermatol. 2010;146:1141–50.

    Article  Google Scholar 

  12. FDA Drug Safety Communication: 5-alpha reductase inhibitors (5-ARIs) may increase the risk of a more serious form of prostate cancer: FDA. 2011.

  13. Turner E, Rainie L. Most Americans rely on their own research to make big decisions, and that often means online searches. Pew Research. 2021.

  14. Fox S, Duggan M. Peer-to-Peer Health Care. Pew Internet. 2013.

  15. Bussey LG, Sillence E. The role of internet resources in health decision-making: a qualitative study. Digit Health. 2019;5:2055207619888073.

    PubMed  PubMed Central  Google Scholar 

  16. Cajita MI, Whitehouse E, Budhathoki C, Hodgson N. Association between Internet use and decision-making preference in older adults. Gerontechnology. 2016;14:97–104.

    Article  Google Scholar 

  17. Clayman ML, Gulbrandsen P, Morris MA. A patient in the clinic; a person in the world. Why shared decision making needs to center on the person rather than the medical encounter. Patient Educ Couns. 2017;100:600–4.

    Article  Google Scholar 

  18. Johnson J. Search engine market share worldwide. Statista. 2021.

  19. Nuti SV, Wayda B, Ranasinghe I, Wang S, Dreyer RP, Chen SI, et al. The use of google trends in health care research: a systematic review. PLoS ONE. 2014;9:e109583.

    Article  Google Scholar 

  20. Google Trends. Google. 2021.

  21. Russo GI, di Mauro M, Cocci A, Cacciamani G, Cimino S, Serefoglu EC, et al. Consulting “Dr Google” for sexual dysfunction: a contemporary worldwide trend analysis. Int J Impot Res. 2020;32:455–61.

    CAS  Article  Google Scholar 

  22. Kim JH, Baek MJ, Sun HY, Lee B, Li S, Khandwala Y, et al. Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: a meta-analysis. PLoS ONE. 2018;13:e0203479.

    Article  Google Scholar 

  23. Del Giudice F, Kasman AM, Ferro M, Sciarra A, De Berardinis E, Belladelli F, et al. Clinical correlation among male infertility and overall male health: a systematic review of the literature. Investig Clin Urol. 2020;61:355–71.

    Article  Google Scholar 

  24. Traish AM. Post-finasteride syndrome: a surmountable challenge for clinicians. Fertil Steril. 2020;113:21–50.

    CAS  Article  Google Scholar 

  25. Stone BV, Forde JC, Levit VB, Lee RK, Te AE, Chughtai B. Trends in internet search activity, media coverage, and patient-centered health information after the FDA safety communications on surgical mesh for pelvic organ prolapse. Int Urogynecol J. 2016;27:1761–6.

    Article  Google Scholar 

  26. Agree EM, King AC, Castro CM, Wiley A, Borzekowski DL. “It’s got to be on this page”: age and cognitive style in a study of online health information seeking. J Med Internet Res. 2015;17:e79.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations



Conceptualization: KA and GEC. Methodology: KA and GEC. Formal Analysis: KA. and GEC. Writing—original draft: KA, TS, MKS, and GEC. Writing—reviewing, and editing: KA, TS, MKS, and GEC. Supervision: GEC and MKS.

Corresponding author

Correspondence to Giovanni E. Cacciamani.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Asanad, K., Sholklapper, T., Samplaski, M.K. et al. Global online interest in finasteride sexual side effects. Int J Impot Res (2022).

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI:


Quick links